Candelanza, Geralyn N.
HRN: 19-09-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
CEFUROXIME 1.5GM (VIAL)
09/23/2024
09/30/2024
IV
1.5g
Q8h
Pneumonia
Waiting Final Action
09/26/2024
CEFUROXIME 500MG (TAB)
09/26/2024
10/03/2024
PO
500mg
BID
CAP LR
Waiting Final Action